- SEK1.26bn
- SEK1.13bn
- SEK441.90m
Brief: Accuray Inc and C-Rad Sign Agreement To Enhance Radixact System Breast Cancer Treatment Capabilities
Brief: C Rad Q2 Operating Profit Rises To SEK 6.0 Mln
Brief: C-RAD: Former Employee Appeals Verdict From Stockholm Patent And Market Court
Brief: C Rad Announces Court Resolution On Former Employee's Claims
Brief: C-Rad Establishes Office In Delhi
Brief: C Rad Q1 Operating Profit Rises To SEK 6.2 Mln
Brief: C-RAD: Patent And Market Court Of Appeal Confirms Co's Entitlement To Beamocular's Invention
Brief: C-Rad Signs Distribution Agreement With South Korean Company
Brief: C Rad Q4 Operating Result Swings To Profit SEK 9.8 Mln
Brief: C-Rad Gets Order Worth SEK 15 Mln
Brief: C Rad Gets Order From Ion Beam Applications
Brief: C Rad AB - Q3 Order Intake Increased 15% To SEK 80.5 mln
Brief: C-RAD: SIGRT Solution Selected By Australian Customers
Brief: C-RAD: Shanghai Proton And Heavy Ion Hospital Decides For Co's SIGRT Solution
Brief: C-Rad And Elekta Expand Sales And Distribution Agreement To Include China
Brief: C Rad Q2 Order Intake Down At SEK 62.3 Mln
Brief: C-RAD Gets Order Worth Around SEK 11 Mln
Brief: C-RAD Signs LoI with Belgium Company Ion Beam Applications
Brief: C-RAD Says Former Employee Files Lawsuit For Compensation